Xu Lixue, Lu Jun, Zhou Minsi, Shi Haiyun, Zheng Jing, Cheng Tianxin, Xu Hui, Yang Dawei, Yong Xingwang, Xu Fang, Xu Chenyue, Dang Yan, Wang Zhan, Zhu Siying, Wang Chunsaier, Li Peng, Wang Zhenchang, Wu Jing, Zhang Yi, Yang Zhenghan
Department of Radiology, Beijing Friendship Hospital, Capital Medical University, No. 95 Yongan Road, Beijing 100050, China.
Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, No. 95 Yongan Road, Beijing 100050, China.
Neuroimage Clin. 2025;45:103713. doi: 10.1016/j.nicl.2024.103713. Epub 2024 Nov 23.
Depression commonly co-occurs with inflammatory bowel disease (IBD). Abnormal glutamate levels in the insula and altered plasma inflammatory biomarkers are observed in IBD and depression. However, the changes in glutamate concentrations in insular subregions in IBD and their relationship with depression and inflammatory markers remain unclear. This study aimed to investigate differences in glutamate concentrations in insular subregions between IBD patients and healthy controls (HCs) and their correlation with depression scores and inflammatory markers.
Forty-two IBD patients (19 active, IBD-A; 23 in remission, IBD-R) and 46 HCs underwent glutamate chemical exchange saturation transfer (GluCEST) magnetic resonance imaging. Blood samples from 37 IBD patients were collected for plasma inflammatory biomarker analysis. GluCEST indices in insular subregions were measured. The Hospital Anxiety and Depression Scale (HADS-D) was used to estimate depression symptoms. Whole-brain voxel-based analysis using one-way ANOVA explored between-group differences in GluCEST indices within the insula. FDR-corrected partial correlation analysis evaluated the relationships between GluCEST, depression symptoms, and inflammatory factors.
GluCEST indices decreased in IBD patients in the left dorsal dysgranular subregion of the insula (dId) (uncorrected p < 0.001, cluster-level FWE-corrected p < 0.05). GluCEST indices in the left dId showed a significant positive correlation with HADS-D in IBD-R (FDR corrected q < 0.05). Additionally, GluCEST indices in the left dId were negatively correlated with CXCL9 (FDR corrected q < 0.05).
State-specific GluCEST alterations in the left dId are a cerebral metabolic feature of IBD. These changes are associated with depression and inflammatory biomarkers, suggesting that the brain-immune-gut axis might underlie depression in IBD patients.
抑郁症常与炎症性肠病(IBD)同时发生。在IBD和抑郁症患者中观察到脑岛谷氨酸水平异常以及血浆炎症生物标志物改变。然而,IBD患者脑岛亚区域谷氨酸浓度的变化及其与抑郁症和炎症标志物的关系仍不清楚。本研究旨在调查IBD患者与健康对照者(HCs)脑岛亚区域谷氨酸浓度的差异及其与抑郁评分和炎症标志物的相关性。
42例IBD患者(19例活动期,IBD-A;23例缓解期,IBD-R)和46例HCs接受了谷氨酸化学交换饱和转移(GluCEST)磁共振成像检查。采集37例IBD患者的血样进行血浆炎症生物标志物分析。测量脑岛亚区域的GluCEST指数。采用医院焦虑抑郁量表(HADS-D)评估抑郁症状。使用单因素方差分析进行基于全脑体素的分析,探讨脑岛内GluCEST指数的组间差异。经FDR校正的偏相关分析评估GluCEST、抑郁症状和炎症因子之间的关系。
IBD患者脑岛左侧背侧颗粒下区(dId)的GluCEST指数降低(未校正p<0.001,聚类水平FWE校正p<0.05)。IBD-R患者左侧dId的GluCEST指数与HADS-D呈显著正相关(FDR校正q<0.05)。此外,左侧dId的GluCEST指数与CXCL9呈负相关(FDR校正q<0.05)。
左侧dId的状态特异性GluCEST改变是IBD的一种脑代谢特征。这些变化与抑郁症和炎症生物标志物相关,提示脑-免疫-肠轴可能是IBD患者抑郁症的潜在机制。